ORYZF (Oryzon Genomics) NonCurrent Deferred Liabilities : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Oryzon Genomics NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Oryzon Genomics's non-current deferred liabilities for the quarter that ended in Sep. 2024 was $0.00 Mil.

Oryzon Genomics NonCurrent Deferred Liabilities Historical Data

The historical data trend for Oryzon Genomics's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics NonCurrent Deferred Liabilities Chart

Oryzon Genomics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

Oryzon Genomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Oryzon Genomics NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Oryzon Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (OTCPK:ORYZF) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

0RDB:UK ORY:Spain ORN:Germany

Address

Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940

Website

http://www.oryzon.com

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.